| Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma (NCT05694871) | Alliance for Clinical Trials in Oncology | 2023-06-07 |
| A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression (NCT06939452) | Yongxu Jia | 2023-06-07 |
| Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC (NCT05776875) | Yale University | 2023-06-07 |
| A Study of DS-7011a in Patients With Systemic Lupus Erythematosus (NCT05638802) | Daiichi Sankyo | 2023-06-07 |
| LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma (NCT05876715) | ERLINDA M GORDON | 2023-06-07 |
| Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults (NCT05874713) | Seqirus | 2023-06-07 |
| Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT05445609) | Emory University | 2023-06-07 |
| Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma (NCT05895864) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-06-07 |
| Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC (NCT05898373) | Peking Union Medical College | 2023-06-07 |
| RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer (NCT05256745) | Georgetown University | 2023-06-06 |
| A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa (NCT05849922) | Sanofi | 2023-06-06 |
| Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease? (NCT06317818) | Centre Hospitalier Universitaire de Liege | 2023-06-06 |
| Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients (NCT05636787) | Insel Gruppe AG, University Hospital Bern | 2023-06-06 |
| Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study (NCT06957834) | National Skin Centre | 2023-06-06 |
| Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) (NCT05881135) | Ohio State University | 2023-06-06 |
| Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders (NCT05792540) | Tanta University | 2023-06-06 |
| A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors (NCT05888831) | Bristol-Myers Squibb | 2023-06-06 |
| 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors (NCT05563272) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2023-06-06 |
| Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide (NCT05768035) | Smart Immune SAS | 2023-06-06 |
| SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) (NCT06125327) | Guangzhou JOYO Pharma Co., Ltd | 2023-06-06 |
| Effects of Antiviral Therapies on Epstein-Barr Virus Replication (NCT05957913) | Massachusetts General Hospital | 2023-06-05 |
| Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia (NCT06924749) | Shandong Cancer Hospital and Institute | 2023-06-05 |
| Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA (NCT05766969) | Pure Green Pharmaceuticals Inc. | 2023-06-05 |
| Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors (NCT05894486) | Peking University | 2023-06-05 |
| Effect of New Topical Preparation for Treatment of Acne Vulgaris (NCT05899699) | Mansoura University | 2023-06-05 |
| Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC (NCT05831969) | Shenyang Tenth People's Hospital | 2023-06-05 |
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors (NCT05797168) | AstraZeneca | 2023-06-05 |
| Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion (NCT05836766) | Beijing Tiantan Hospital | 2023-06-05 |
| A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). (NCT05886777) | Pfizer | 2023-06-05 |
| Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids (NCT05123040) | Masonic Cancer Center, University of Minnesota | 2023-06-05 |
| First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer (NCT05141149) | Prestige Biopharma Limited | 2023-06-05 |
| Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease (NCT05771428) | AbbVie | 2023-06-05 |
| Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance (NCT05703009) | QOL Medical, LLC | 2023-06-05 |
| A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT05908409) | IDP Discovery Pharma S.L. | 2023-06-05 |
| Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy (NCT05583552) | GCP-Service International West GmbH | 2023-06-05 |
| Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy (NCT05847920) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-06-04 |
| CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer (NCT07595835) | M.R. Meijerink | 2023-06-04 |
| Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial (NCT06429384) | Beijing Tiantan Hospital | 2023-06-04 |
| Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization (NCT05670028) | Beijing Tiantan Hospital | 2023-06-04 |
| A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML (NCT05199051) | Centre Antoine Lacassagne | 2023-06-03 |
| A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) (NCT05692492) | Guangdong Raynovent Biotech Co., Ltd | 2023-06-03 |
| Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis (NCT05882812) | ZetrOZ, Inc. | 2023-06-03 |
| Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer (NCT05621889) | Centre hospitalier de l'Université de Montréal (CHUM) | 2023-06-02 |
| Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug (NCT05793307) | GeneCradle Inc | 2023-06-02 |
| Furoscix in Heart Failure Patients With Diuretic Resistance (NCT05528588) | University of Texas Southwestern Medical Center | 2023-06-02 |
| A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer (NCT05838521) | Yale University | 2023-06-02 |
| A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract (NCT05868265) | Memorial Sloan Kettering Cancer Center | 2023-06-02 |
| Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (NCT05753930) | Hansa Biopharma AB | 2023-06-02 |
| Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation (NCT05672173) | City of Hope Medical Center | 2023-06-02 |
| Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) (NCT06621888) | Fenix Innovation Group | 2023-06-02 |
| Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET) (NCT05700721) | M.D. Anderson Cancer Center | 2023-06-02 |
| Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). (NCT05681039) | M.D. Anderson Cancer Center | 2023-06-02 |
| A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia (NCT07278830) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2023-06-02 |
| Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study (NCT04992507) | Ohio State University Comprehensive Cancer Center | 2023-06-02 |
| COMP-4 Supplementation and Brachial Artery FMD (NCT05595915) | University of California, Los Angeles | 2023-06-01 |
| Tranexamic Acid With Microneedling in Melasma (NCT05909072) | Zagazig University | 2023-06-01 |
| Allopurinol and Pathogenesis of Cirrhosis (NCT07033533) | Tanta University | 2023-06-01 |
| Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy (NCT06125834) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
| The Effect of Prior Learning on Word Learning (NCT05921188) | University of Arizona | 2023-06-01 |
| Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women (NCT05552053) | Cedars-Sinai Medical Center | 2023-06-01 |
| Anrotinib and Tirelizumab in First-line Treatment of RM-NPC (NCT05981157) | Zhongshan People's Hospital, Guangdong, China | 2023-06-01 |
| Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome (NCT05845723) | Peking Union Medical College Hospital | 2023-06-01 |
| A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC (NCT05844150) | Biotheus Inc. | 2023-06-01 |
| Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) (NCT06371482) | Hebei Medical University Fourth Hospital | 2023-06-01 |
| CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC (NCT05774899) | Glenn J. Hanna | 2023-06-01 |
| A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults (NCT05905575) | Ohio State University | 2023-06-01 |
| Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer (NCT05841134) | The First Affiliated Hospital of Zhengzhou University | 2023-06-01 |
| MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma (NCT05655312) | Perspective Therapeutics | 2023-06-01 |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation (NCT05321498) | Inmune Bio, Inc. | 2023-06-01 |
| A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC (NCT05877820) | RenJi Hospital | 2023-06-01 |
| Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients (NCT05870514) | Xiaobo Yang, MD | 2023-06-01 |
| Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer (NCT05882630) | Fujian Cancer Hospital | 2023-06-01 |
| PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) (NCT06074692) | Ruijin Hospital | 2023-06-01 |
| Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury (NCT05870189) | University of Minnesota | 2023-06-01 |
| Mitochondrial Complex I Dysfunction in PWS (NCT03831425) | The Hospital for Sick Children | 2023-06-01 |
| Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases (NCT05894837) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-01 |
| FMT for MS Patients (NCT04150549) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2023-06-01 |
| Effectiveness Comparison Between Continuous Cryotherapy and Ice Pack Therapy After Anterior Cruciate Ligament Reconstruction Surgery (NCT06629285) | University Medical Center Ho Chi Minh City (UMC) | 2023-06-01 |
| Daratumumab in STK11 Mutated NSCLC (NCT05807048) | NYU Langone Health | 2023-06-01 |
| Combined Ketorolac Bupivacaine Versus Bupivacaine Alone for TAP Block in Children Undergoing Lower Abdominal Surgeries (NCT06267820) | Sohag University | 2023-06-01 |
| A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study (NCT06752343) | Wroclaw Medical University | 2023-06-01 |
| A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 (NCT03595995) | United BioPharma | 2023-06-01 |
| Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors (NCT05824494) | Women's Hospital School Of Medicine Zhejiang University | 2023-06-01 |
| Cluster Randomised Control Trial of the BodyKind Body Image Programme (NCT06076993) | University College Dublin | 2023-06-01 |
| A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma (NCT05933967) | Shandong Cancer Hospital and Institute | 2023-06-01 |
| TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria (NCT05883176) | Sun Yat-sen University | 2023-06-01 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B (NCT07190742) | Grand Theravac Life Sciences (Nanjing) Co., Ltd. | 2023-06-01 |
| LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19 (NCT05783180) | Jose David Suarez, MD | 2023-06-01 |
| Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) (NCT04789044) | Major Extremity Trauma Research Consortium | 2023-06-01 |
| Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC (NCT05917431) | Peking University Cancer Hospital & Institute | 2023-06-01 |
| EO4010 in Previously Treated Metastatic Colorectal Carcinoma (NCT05589597) | Enterome | 2023-06-01 |
| Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease (NCT03806478) | Aphios | 2023-06-01 |
| ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) (NCT05889273) | MapLight Therapeutics | 2023-06-01 |
| Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer (NCT05872412) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-06-01 |
| EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer (NCT05498389) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2023-06-01 |
| Janus Kinase Inhibition in Sarcoidosis (NCT05696795) | Yale University | 2023-06-01 |
| Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy (NCT05803434) | Meyer Children's Hospital IRCCS | 2023-06-01 |
| Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome (NCT06071481) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-06-01 |
| A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11) (NCT05755737) | University of Calgary | 2023-06-01 |
| Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. (NCT05732155) | HaEmek Medical Center, Israel | 2023-06-01 |